Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

CUSIP: 23954D109

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,960,784
Total 13F shares
81,407,211
Share change
-4,405,314
Total reported value
$758,405,136
Put/Call ratio
88%
Price per share
$9.32
Number of holders
183
Value change
-$19,414,545
Number of buys
112
Number of sells
75

Quarterly Holders Quick Answers

What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q4 2025

As of 31 Dec 2025, Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by 183 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,407,211 shares. The largest 10 holders included BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, FMR LLC, Vestal Point Capital, LP, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P., Pictet Asset Management Holding SA, AIGH Capital Management LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 183 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.